Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma

BACKGROUND: We investigated the contribution of subsequent therapy for advanced hepatocellular carcinoma refractory or intolerant to sorafenib. Further, we investigated the impact of sorafenib on overall survival using individual data. METHODS: We reviewed the medical records of patients with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Terashima, Takeshi, Yamashita, Tatsuya, Horii, Rika, Arai, Kuniaki, Kawaguchi, Kazunori, Kitamura, Kazuya, Yamashita, Taro, Sakai, Yoshio, Mizukoshi, Eishiro, Honda, Masao, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886418/
https://www.ncbi.nlm.nih.gov/pubmed/27246496
http://dx.doi.org/10.1186/s12885-016-2380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886418/
https://www.ncbi.nlm.nih.gov/pubmed/27246496
http://dx.doi.org/10.1186/s12885-016-2380-4

Ejemplares similares